Skip to content

A study of ASP3082 in adults with advanced solid tumors

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-501590-39-00
Acronym
3082-CL-0101
Enrollment
90
Registered
2023-11-17
Start date
2024-05-22
Completion date
Unknown
Last updated
2025-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumor

Interventions

None listed

Sponsors

Astellas Pharma Inc
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026